Seems like the same story..we think they are setting up to sell the company. After the part sale closes, the remaining part of the lab could be sold to some other entity and Opko would become a research and development company (Modex). As a stand alone like this, it would be attractive to other pharma companies. We’ll be trading this from here on out. Synergies have momentum to the upside time being.
Market Data 
Markets 
AI
